CNI-1493

· Ferring Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNI-1493, covering 2012-08-23 to 2012-08-23. Get the full timeline:

Most recent: Clinical Trial Update: CNI-1493 for Treatment of Moderate to Severe Crohn's Disease [Phase 2]